Study of the Prostatex Plus effectiveness in patients after transurethral resection for benign prostatic hyperplasia

Number №4, 2024 - page 83-88

DOI: 10.29188/2222-8543-2024-17-4-83-88

For citation: Neymark A.I., Nozdrachev N.A., Neymark A.B., Neymark B.A., Sevryukov F.A., Samazhanova R.S., Mushtarieva A.R., Kovaleva Yu.S. Study of the Prostatex Plus effectiveness in patients after transurethral resection for benign prostatic hyperplasia. Experimental and Clinical Urology 2024;17(4):83-88; https://doi.org/10.29188/2222-8543-2024-17-4-83-88

Neymark A.I. Nozdrachev N.A. Neymark A.B. Neymark B.A. Sevryukov F.A. Samazhanova R.S. Mushtarieva A.R. Kovaleva Yu.S.

Information about authors:

Neymark A.I. – Dr. Sci., Professor, Head of the Department of Urology and Andrology with advanced professional training, Altai State Medical University of the Ministry of Health of the Russian Federation; Barnaul, Russia; RSCI Author ID 527832, https://orcid.org/0000-0002-5741-6408
Nozdrachev N.A. – PhD, Associate Professor of the Department of Urology and Andrology with advanced professional training, Altai State Medical University of the Ministry of Health of the Russian Federation, Urologist at the Department of urology, Private Healthcare Institution «Clinical hospital» Russian Railways-Medicine; Barnaul, Russia; RSCI Author ID 648075, https://orcid.org/0000-0003-3937-7270
Neymark B.A. – Dr.Sci., Doctor of Medicine, Professor of the Department of Urology and Andrology with advanced professional training, Altai State Medical University of the Ministry of Health of the Russian Federation, Urologist at the Department of urology, Private Healthcare Institution «Clinical hospital» Russian Railways-Medicine; Barnaul, Russia; RSCI Author ID 78868442, https://orcid.org/0000-0001-8009-3777
Neymark A.B. – student, member of Student Scientific Society, Department of Urology and Andrology with advanced professional training, Altai State Medical University of the Ministry of Health of the Russian Federation; Barnaul, Russia; RSCI Author ID 1229767, https://orcid.org/0009-0003-0696-0627
Sevryukov F.A. – Dr.Sci., Doctor of Medicine, Professor, Head of the Department of Urology and Andrology with advanced professional training named after E.V. Shakhov, Privolzhsky Research Medical University; Nizhny Novgorod, Russia; RSCI Author ID 431692, https://orcid.org/0000-0001-5120-2620
Mushtarieva A.R. – student, member of Student Scientific Society, Department of Urology and Andrology with advanced professional training, Altai State Medical University of the Ministry of Health of the Russian Federation; Barnaul, Russia
Samazhanova R.S. – student, member of Student Scientific Society, Department of Urology and Andrology with advanced professional training, Altai State Medical University of the Ministry of Health of the Russian Federation; Barnaul, Russia
Kovaleva Yu.S. – Altai State Medical University of the Ministry of Health of the Russian Federation; Barnaul, Russia; RSCI Author ID 181368, https://orcid.org/0000-0002-4401-3722

2860

Download PDF

Introduction. The course of the postoperative period in patients with benign prostatic hyperplasia (BPH) who have undergone transurethral resection (TUR) remains an important issue. Adequate relaxation of the muscle tone of the prostatic urethra and bladder neck is crucial in the postoperative period.

Materials and methods. The article presents the results of the study evaluating the drug Prostatex plus in patients with BPH who underwent transurethral resection of the prostate (TURP).

Results. The results showed the most significant efficacy of Prostatex Plus when it was taken pre- and postoperatively (5 days before and 10 days after TURP) for patients with BPH if compared with the purely postoperative use of indomethacin and Prostatex Plus (10 days after TURP). The efficacy is confirmed by significantly improved urinary flow and the best pain relief in the postoperative period. Thus, the drug should be prescribed for the pre- and postoperative management of these patients.

Conclusion. The use of Prostatex Plus can significantly improve the quality of life of patients in the postoperative period after TURP for BPH.

Attachment	Size
Download	1.6 MB

Keywords: benign prostatic hyperplasia; BPH; transurethral resection of the prostate; Prostatex Plus

Study of the Prostatex Plus effectiveness in patients after transurethral resection for benign prostatic hyperplasia

Other issue articles